Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

24.18

+1.62 (7.18%)

At close: Jul 30, 2026, 4:00 PM EDT

24.20

+0.02 (0.08%)

After-hours: Jul 30, 2026, 6:34 PM EDT

Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	308.08	276.98	178.96	170.28	185.31	154.34
Revenue Growth	50.13%	54.77%	5.10%	-8.11%	20.06%	56.88%
Cost of Revenue	75.25	71.36	72.08	75.55	57.91	49.3
Gross Profit	232.83	205.62	106.88	94.72	127.4	105.04
Selling, General & Admin	180.38	167.27	157.57	172.51	184.13	169.97
Depreciation & Amortization Expenses	1.7	1.7	1.7	1.7	1.7	1.7
Research & Development	88.21	93.77	102.95	122.12	141.76	142.34
Other Operating Expenses	-	-	7.21	25.43	-	-
Total Operating Expenses	270.29	262.74	269.43	321.76	327.59	314.01
Operating Income	-37.46	-57.12	-162.55	-227.04	-200.19	-208.97
Interest Expense	-11.51	-11.78	-11.58	-13.8	-4.24	-
Other Non-Operating Income (Expense)	8.71	9.44	14.53	15.53	4.06	1.67
Total Non-Operating Income (Expense)	-2.8	-2.33	2.95	1.73	-0.18	1.67
Pretax Income	-40.26	-59.46	-159.6	-225.3	-200.37	-207.3
Net Income	-63.99	-59.46	-159.6	-225.3	-200.37	-207.3
Minority Interest in Earnings	-0.14	0.04	-0.1	-0.05	-0.18	-0.02
Net Income to Common	-63.85	-59.5	-159.49	-225.25	-200.19	-207.28
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	155	152	147	144	143	140
Shares Outstanding (Diluted)	158	152	147	144	143	140
Shares Change	5.90%	3.14%	1.88%	1.31%	1.54%	6.96%
EPS (Basic)	-0.41	-0.39	-1.08	-1.56	-1.40	-1.48
EPS (Diluted)	-0.41	-0.39	-1.08	-1.56	-1.40	-1.48
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	-48.95	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-	-0.32	-0.67	-1.16	-1.41	-1.81
Gross Margin	75.57%	74.24%	59.72%	55.63%	68.75%	68.06%
Operating Margin	-12.16%	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%
Profit Margin	-20.77%	-21.47%	-89.18%	-132.32%	-108.13%	-134.31%
FCF Margin	-	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%
EBITDA	-37.46	-39.29	-143.29	-204.8	-179.27	-195.01
EBITDA Margin	-12.16%	-14.19%	-80.07%	-120.28%	-96.74%	-126.35%
EBIT	-37.46	-57.12	-162.55	-227.04	-200.19	-208.97
EBIT Margin	-12.16%	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%

SEC Filings: 10-K · 10-Q